Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AEHR | Common Stock | Options Exercise | $52.5K | +25K | +56.3% | $2.10* | 69.4K | Nov 4, 2021 | Direct | |
transaction | AEHR | Common Stock | Sale | -$627K | -25K | -36.02% | $25.08 | 44.4K | Nov 4, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AEHR | Incentive Stock Option (right to buy) | Options Exercise | $0 | -25K | -100% | $0.00* | 0 | Nov 4, 2021 | Common Stock | 25K | $2.10 | Direct | F3 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.5718 to $25.5069, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. |
F2 | The amount reported includes shares subject to unvested restricted stock units. |
F3 | One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
Ex. 24-Power of Attorney